DaVita Inc
Gesloten
SectorGezondheidszorg
213.08 0.91
Overzicht
Wijziging aandelenprijs
24u
Min
210.09
Max
213.96
Inkomsten | -804M 275M |
|---|---|
Verkoop | -204M 3.4B |
K/W Sectorgemiddelde | 20.2 50.958 |
EPS | 2.87 |
Winstmarge | 8.052 |
Werknemers | 78,000 |
EBITDA | -62M 655M |
Aanbevelingen | Buy |
|---|---|
12 Maanden Prognose | +0.03% upside |
Volgende Winsten | 4 aug 2026 |
|---|
Marktkapitalisatie | 3.3B 13B |
|---|---|
Vorige openingsprijs | 212.17 |
Vorige sluitingsprijs | 213.08 |
Nieuwssentiment
By Acuity
47%
53%
140 / 342 Rangschikking in Healthcare
DaVita Inc Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Over DaVita Inc
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.